These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27562221)

  • 61. Efficacy of inorganic bovine bone combined with leukocyte and platelet-rich fibrin or collagen membranes for treating unfavorable periodontal infrabony defects: Randomized non-inferiority trial.
    Rexhepi I; Paolantonio M; Romano L; Serroni M; Santamaria P; Secondi L; Paolantonio G; Sinjari B; De Ninis P; Femminella B
    J Periodontol; 2021 Nov; 92(11):1576-1587. PubMed ID: 33547808
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of platelet rich fibrin in the treatment of human intrabony defects with or without bone graft: A randomized controlled trial.
    Chandradas ND; Ravindra S; Rangaraju VM; Jain S; Dasappa S
    J Int Soc Prev Community Dent; 2016 Aug; 6(Suppl 2):S153-9. PubMed ID: 27652249
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gingival crevicular fluid vascular endothelial cell growth factor and platelet-derived growth factor-BB release profile following the use of perforated barrier membranes during treatment of intrabony defects: a randomized clinical trial.
    Gamal AY; Abdel-Ghaffar KA; Iacono VJ
    J Periodontal Res; 2016 Jun; 51(3):407-16. PubMed ID: 26549803
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
    Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
    J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 1% alendronate gel as local drug delivery in the treatment of Class II furcation defects: a randomized controlled clinical trial.
    Pradeep AR; Kumari M; Rao NS; Naik SB
    J Periodontol; 2013 Mar; 84(3):307-15. PubMed ID: 22554293
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 1.2% Rosuvastatin Versus 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Placebo-Controlled Clinical Trial.
    Pradeep AR; Garg V; Kanoriya D; Singhal S
    J Periodontol; 2016 Jul; 87(7):756-62. PubMed ID: 26878748
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative Evaluation of the Efficacy of Platelet-rich Fibrin and Calcium Phosphosilicate Putty alone and in Combination in the Treatment of Intrabony Defects: A Randomized Clinical and Radiographic Study.
    Agrawal I; Chandran S; Nadig P
    Contemp Clin Dent; 2017; 8(2):205-210. PubMed ID: 28839404
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinicoradiographic evaluation of advanced-platelet rich fibrin block (A PRF + i PRF + nanohydroxyapatite) compared to nanohydroxyapatite alone in the management of periodontal intrabony defects.
    Mallappa J; Vasanth D; Gowda TM; Shah R; Gayathri GV; Mehta DS
    J Indian Soc Periodontol; 2022; 26(4):359-364. PubMed ID: 35959304
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial.
    Pradeep AR; Thorat MS
    J Periodontol; 2010 Feb; 81(2):214-22. PubMed ID: 20151799
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical and radiographic evaluation of platelet-rich fibrin and bone graft material (β-tricalcium phosphate + hydroxyapatite) in the treatment of intrabony defects of periodontitis patients: a randomized controlled trial.
    Baghele O; Thorat M; Malpani P
    Quintessence Int; 2023 Jun; 54(6):472-483. PubMed ID: 36825719
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Titanium-prepared platelet-rich fibrin provides advantages on periodontal healing: A randomized split-mouth clinical study.
    Arabaci T; Albayrak M
    J Periodontol; 2018 Mar; 89(3):255-264. PubMed ID: 29543995
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R; Schreiber D; Flores-de-Jacoby L
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical efficacy of subgingivally-delivered 0.75% boric acid gel as an adjunct to mechanotherapy in chronic periodontitis: A randomized, controlled clinical trial.
    Kanoriya D; Singhal S; Garg V; Pradeep AR; Garg S; Kumar A
    J Investig Clin Dent; 2018 Feb; 9(1):. PubMed ID: 28474437
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial.
    Pradeep AR; Rao NS; Bajaj P; Kumari M
    J Periodontol; 2013 Jan; 84(1):24-31. PubMed ID: 22420871
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
    Mengel R; Soffner M; Flores-de-Jacoby L
    J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical evaluation of autologous platelet rich fibrin in horizontal alveolar bony defects.
    Joseph V R; Sam G; Amol NV
    J Clin Diagn Res; 2014 Nov; 8(11):ZC43-7. PubMed ID: 25584315
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of intrabony defects treated with platelet-rich fibrin or autogenous bone graft: A comparative analysis.
    Mathur A; Bains VK; Gupta V; Jhingran R; Singh GP
    Eur J Dent; 2015; 9(1):100-108. PubMed ID: 25713492
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial.
    Pradeep AR; Kumari M; Rao NS; Martande SS; Naik SB
    J Periodontol; 2013 Jul; 84(7):871-9. PubMed ID: 23030241
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in humans.
    Ouyang XY; Qiao J
    Chin Med J (Engl); 2006 Sep; 119(18):1511-21. PubMed ID: 16996004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.